CEFALEXIN, 250mg, caps.

STD DORACEFX2C-

Valid Article

Former Code(s): -X DORAZFR0583
6.2.1 - Access group antibiotics
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J01DB01
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
The product is part of at least one Kit. A kit is a collection of products (medical and/or logistic) that are needed for a certain intervention in emergency. The choice and quantity of the articles reflects the MSF protocols for this specific situation. The use of Kits allows to start an intervention without a detailed evaluation.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   

Add Kit To Wishlist

   

CEFALEXIN

Therapeutic Action

First-generation cephalosporin antibacterial

Indications

Treatment of mild-moderate staphylococcal skin infections

Completion treatment following parental therapy with cloxacillin for the treatment of severe staphylococcal infections

Instructions for use

The granules or powder for oral suspension are intended for paediatric use. To be reconstituted with filtered water.

Storage

  • Below 25°C ‐ Protect from sunlight ‐ Protect from humidity
  • Reconstituted oral solution: keep refrigerated between 2°C and 8°C
  • After reconstitution, the refrigerated oral suspension keeps for a maximum of 14 days (or follow the manufacturer's instructions).